δ-FeOOH: a superparamagnetic material for controlled heat release under AC magnetic field

Experimental evidences on its in vitro use reveal that δ-FeOOH is a material that release-controlled amount of heat if placed under an AC magnetic field. δ-FeOOH nanoparticles were prepared by precipitating Fe(OH) 2 in alkaline solution followed by fast oxidation with H 2 O 2 . XRD and 57 Fe Mössbau...

Full description

Saved in:
Bibliographic Details
Published inJournal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology Vol. 15; no. 4
Main Authors Chagas, Poliane, da Silva, Adilson Cândido, Passamani, Edson Caetano, Ardisson, José Domingos, de Oliveira, Luiz Carlos Alves, Fabris, José Domingos, Paniago, Roberto M., Monteiro, Douglas Santos, Pereira, Márcio César
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Netherlands 01.04.2013
Springer
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Experimental evidences on its in vitro use reveal that δ-FeOOH is a material that release-controlled amount of heat if placed under an AC magnetic field. δ-FeOOH nanoparticles were prepared by precipitating Fe(OH) 2 in alkaline solution followed by fast oxidation with H 2 O 2 . XRD and 57 Fe Mössbauer spectroscopy data confirmed that δ-FeOOH is indeed the only iron-bearing compound in the produced sample. TEM images evidence that the averaged particle sizes for this δ-FeOOH sample is 23 nm. Magnetization measurements indicate that these δ-FeOOH particles behave superparamagnetically at 300 K; its saturation magnetization was found to be 13.2 emu g −1 ; the coercivity and the remnant magnetization were zero at 300 K. The specific absorption rate values at 225 kHz were 2.1, 6.2, and 34.2 W g −1 , under 38, 64, and 112 mT, respectively. The release rate of heat can be directly controlled by changing the mass of δ-FeOOH nanoparticles. In view of these findings, the so-prepared δ-FeOOH is a real alternative to be further tested as a material for medical practices in therapies involving magnetic hyperthermia as in clinical oncology.
ISSN:1388-0764
1572-896X
DOI:10.1007/s11051-013-1544-2